2020 Oxygen Radicals Gordon Research Conference (GRC) and Gordon Research Seminar (GRS)
2020年氧自由基戈登研究会议(GRC)和戈登研究研讨会(GRS)
基本信息
- 批准号:9912443
- 负责人:
- 金额:$ 2.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-22 至 2021-01-21
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAgeAgingApplications GrantsApplied ResearchAreaAtmosphereAwardBasic ScienceBiologyCaliforniaCell physiologyCessation of lifeChemicalsChemistryCollaborationsCommunicationCountryDiagnosticDiseaseElevatorEndoplasmic ReticulumEnsureEnvironmentEthnic OriginEventFDA approvedFailureFertilizationFosteringFree RadicalsFunctional disorderFundingFutureGenderGoalsGovernmentHealthHomeostasisHourIllinoisIncentivesIndustryIronKnowledgeLinkLipidsLocationMedicineMetabolicMetabolismMethodologyMitochondriaNationalitiesOralOrganellesOxidantsOxidation-ReductionParticipantPharmaceutical PreparationsPlayPoliciesPost-Translational Protein ProcessingPostdoctoral FellowPublished CommentReactive Oxygen SpeciesRegulationResearchResearch PersonnelResearch Project GrantsRheaRoleRunningScientistSenior ScientistSocial PlanningStudentsTherapeuticTranslationsTravelTwitterUnderrepresented MinorityUnited StatesUnited States National Institutes of HealthUniversitiesVermontWomanbasecareercareer developmentclinical developmentcostdrug developmenteducational atmosphereexperiencegraduate studenthealthspaninnovationinquiry-based learninglecturesmeetingsnovelpeerpostersprogramsproteostasisresponsesenescencesensorsocialstem cellssymposiumtherapeutic developmenttooltumor metabolism
项目摘要
Project Summary
This conference grant proposal seeks funds for a Gordon Research Conference (GRC) on Oxygen Radicals:
Chemical Reactivity, Metabolism, and Opportunities for Therapeutic Development to be held in Ventura CA
February 2-7, 2020, in conjunction with a Gordon Research Seminar (GRS) for trainees, organized by two
trainees (Cheryl van de Wetering, and Rhea Bovee), to be held immediate prior to the GRC, February 1-2, 2020
at the same location. We present an exciting program that brings together diverse fields of oxidant research,
integrating recent discoveries of new oxidant species, with methodological advances, studies of biology,
organelle dysfunction and metabolism, and aging, and plenary and round table discussions focusing on redox-
based drugs in clinical development. The program includes senior scientists (giving the keynote lectures), as
was as junior and mid-career scientists, and we have 10 slots for invited talks from submitted abstracts. Speakers
are from academia, industry and the NIH, represent 19 countries and will be sharing their latest discoveries in
nine sessions: Keynote session I: Oxygen Radicals: connecting chemistry with biology and medicine;
Mitochondria from energy power houses to metabolite regulators; Oxygen radicals in stem cell function,
senescence and aging; Redox in translation: Hurdles and ways forward toward therapeutics; Endoplasmic
reticulum-redox control of proteostasis and dysregulation in disease; Reactive lipids in death, homeostasis and
as therapeutics: Ferroptosis, and beyond; Advances in redox sensors, probes, and diagnostics; Oxygen radicals
in metabolism; Keynote session II: Technical advances in the study of oxygen radicals; opportunities and
challenges. Other conference highlights are the power hour and representation by women with a twitter feed
#REDOXWOMEN and assurance that at least 40% of all presenters or discussion leaders are women. We will
have elevator pitch sessions to highlight posters, and a policy of first questions by trainees. We will have welcome
tables and social events to be inclusive of new attendees and continue the tradition of the Iron Bolt Award for
the most notable comment. Collectively, this program will ensure a vibrant and collegial atmosphere to share the
top discoveries in research on oxygen radicals, their involvement in disease and aging and potential avenues for
therapeutic development.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yvonne M. W. Janssen-Heininger其他文献
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment
小分子介导的氧化还原酶 ERO1A 的抑制通过损害肿瘤微环境中的血管内皮生长因子和程序性死亡配体 1 来抑制侵袭性乳腺癌
- DOI:
10.1038/s41419-025-07426-1 - 发表时间:
2025-02-17 - 期刊:
- 影响因子:9.600
- 作者:
Ersilia Varone;Michele Retini;Alessandro Cherubini;Alexander Chernorudskiy;Alice Marrazza;Andrea Guidarelli;Alfredo Cagnotto;Marten Beeg;Marco Gobbi;Stefano Fumagalli;Marco Bolis;Luca Guarrera;Maria Chiara Barbera;Chiara Grasselli;Augusto Bleve;Daniele Generali;Manuela Milani;Michele Mari;Mario Salmona;Giovanni Piersanti;Giovanni Bottegoni;Massimo Broggini;Yvonne M. W. Janssen-Heininger;Jaehyung Cho;Orazio Cantoni;Ester Zito - 通讯作者:
Ester Zito
Yvonne M. W. Janssen-Heininger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yvonne M. W. Janssen-Heininger', 18)}}的其他基金
Glutaredoxin, Glutathione Metabolism and Lung Cancer
谷氧还蛋白、谷胱甘肽代谢与肺癌
- 批准号:
10657945 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Collagen Oxidation, Myofibroblast Activation and Age-Associated Pulmonary Fibrosis
胶原蛋白氧化、肌成纤维细胞激活和年龄相关性肺纤维化
- 批准号:
10532853 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别:
Collagen Oxidation, Myofibroblast Activation and Age-Associated Pulmonary Fibrosis
胶原蛋白氧化、肌成纤维细胞激活和年龄相关性肺纤维化
- 批准号:
10445737 - 财政年份:2021
- 资助金额:
$ 2.5万 - 项目类别:
S-glutathionylation chemistry in fibrotic lung remodeling
纤维化肺重塑中的 S-谷胱甘肽化学
- 批准号:
10585922 - 财政年份:2017
- 资助金额:
$ 2.5万 - 项目类别:
S-glutathionylation chemistry in fibrotic lung remodeling
纤维化肺重塑中的 S-谷胱甘肽化学
- 批准号:
10320789 - 财政年份:2017
- 资助金额:
$ 2.5万 - 项目类别:
Redox-based Fas signaling in allergic airway disease
过敏性气道疾病中基于氧化还原的 Fas 信号传导
- 批准号:
7822474 - 财政年份:2009
- 资助金额:
$ 2.5万 - 项目类别:
Epithelial JNK-TGFb1 Signaling Axis in Airway Remodeling
气道重塑中的上皮 JNK-TGFb1 信号轴
- 批准号:
7367482 - 财政年份:2008
- 资助金额:
$ 2.5万 - 项目类别:
Epithelial JNK-TGFb1 Signaling Axis in Airway Remodeling
气道重塑中的上皮 JNK-TGFb1 信号轴
- 批准号:
7644952 - 财政年份:2008
- 资助金额:
$ 2.5万 - 项目类别:
Epithelial JNK-TGFb1 Signaling Axis in Airway Remodeling
气道重塑中的上皮 JNK-TGFb1 信号轴
- 批准号:
8459777 - 财政年份:2008
- 资助金额:
$ 2.5万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Research Grant














{{item.name}}会员




